Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
65 hedge funds and large institutions have $80.1M invested in Akoya BioSciences in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 7 closing their positions.
9,850% more call options, than puts
Call options by funds: $199K | Put options by funds: $2K
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
19% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 21
7% more capital invested
Capital invested by funds: $74.9M → $80.1M (+$5.22M)
5% more funds holding
Funds holding: 62 → 65 (+3)
2.76% less ownership
Funds ownership: 32.83% → 30.07% (-2.8%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCA
Peddock Capital Advisors
Braintree,
Massachusetts
|
+$1.02M |
| 2 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$620K |
| 3 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
+$494K |
| 4 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
+$306K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$240K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$2.62M |
| 2 |
Millennium Management
New York
|
-$1.6M |
| 3 |
RI
RTW Investments
New York
|
-$1.57M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.38M |
| 5 |
Renaissance Technologies
New York
|
-$686K |
AKYA Hedge Fund Activity: Q4 2023 in Review
65 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q4 2023, worth a combined $80.1M — up 7% from $74.9M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new AKYA positions and 7 closed out — a net gain of 3 holders — while 25 added to existing stakes and 21 trimmed.
The largest buyer was Peddock Capital Advisors, adding an estimated $1.02M. The largest seller was Kent Lake Capital, cutting an estimated $2.62M.
- 65 institutional investors held Akoya BioSciences (AKYA) as of Q4 2023, up from 62 in Q3 2023.
- Funds reported $80.1M of Akoya BioSciences stock for Q4 2023, up 7% quarter-over-quarter.
- 10 funds opened new Akoya BioSciences positions in Q4 2023 and 7 closed out, a net change of +3 holders.
- The largest Akoya BioSciences buyer in Q4 2023 was Peddock Capital Advisors, an estimated $1.02M added.
- The largest Akoya BioSciences seller in Q4 2023 was Kent Lake Capital, an estimated $2.62M sold.
Based on aggregated 13F filings for Q4 2023.